MedTrace Logo

The Effect of Levonorgestrel Intrauterine System in Preventing Endometrial Polyps Recurrence

NCT06620939 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 558

Last updated 2024-10-04

No results posted yet for this study

Summary

The goal of this clinical trial is to determine whether the LNG-IUS is more effective to that of expectant in preventing endometrial polyp recurrence after hysteroscopic polypectomy.

Researchers will compare LNG-IUS to expectant management to see if LNG-IUS works to reduce the recurrence rate of endometrial polyps.

Participants will:

Receive Mirena placement or not after hysteroscopic polypectomy； Be scheduled for a follow-up with TVCD to screen for endometrial polyps recurrence every 6 months.

Conditions

  • Endometrial Polyp

Interventions

DRUG

Levonorgestrel Intrauterine System (LNG-IUS)

Participants in the intervention group will receive Mirena placement after hysteroscopic polypectomy

Sponsors & Collaborators

  • Nanjing Maternity and Child Health Care Hospital

    collaborator OTHER

  • Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

    collaborator OTHER

  • Shanghai First Maternal and Infant Health Hospital affiliated to Tongji University Medical School

    collaborator OTHER

  • RenJi Hospital

    collaborator OTHER

  • Zhang Jian

    lead OTHER

Principal Investigators

  • Jian Zhang · International Peace Maternity and Child Health Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
48 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-01
Primary Completion
2028-12-31
Completion
2028-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06620939 on ClinicalTrials.gov